Roche

weight loss drugs obesity
Biotech

Roche's obesity ambition not reliant on one megablockbuster

Roche’s head of metabolic development said the company is firing “on full cylinders” to get a phase 3 trial of its GLP-1/GIP drug launched next year.
James Waldron Sep 23, 2025 7:45am
Roche Teresa Graham Pharma Day

Roche unveils strategy to become 'top 3' obesity company

Sep 22, 2025 8:05am
An arrow incrementally going up stairs before pointing straight up Blue background

Roche reports phase 3 breast cancer victory for oral SERD

Sep 22, 2025 7:25am
Measuring tape on top of cash

What’s next for Roche’s expensive obesity pipeline?

Sep 19, 2025 10:16am
liver

Roche becomes MASH player via $3.5B deal for 89bio, ph. 3 drug

Sep 18, 2025 5:02am
Two fencers spar in a stadium

Eye disease biotech launches with $100M, Roche rival in clinic

Sep 17, 2025 6:30am